Investing.com - Gamida Cell (NASDAQ: GMDA) reported second quarter EPS of $-0.310, $0.11 worse than the analyst estimate of $-0.200. Revenue for the quarter came in at $0.00 versus the consensus estimate of $165K.
Gamida Cell's stock price closed at $1.220. It is down -41.630% in the last 3 months and down -63.160% in the last 12 months.
Gamida Cell saw 4 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Gamida Cell's stock price’s past reactions to earnings here.
According to InvestingPro, Gamida Cell's Financial Health score is "weak performance".
Check out Gamida Cell's recent earnings performance, and Gamida Cell's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar